( NASDAQ-NMS:SSRX )

News from 3sbio inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 07, 2016, 04:07 ET 3SBio's PEG-irinotecan Wins IND Approval From China FDA

SHENYANG, China, March 7, 2016 /PRNewswire/ -- 3SBio Inc., ("3SBio") a leading biotechnology company based in China focusing on researching,...


Mar 04, 2016, 05:23 ET 3SBio Inc. Announces Expansion of its Leadership Team

3SBio Inc. (Hong Kong: 1530)  ("3SBio" and together with its subsidiaries the "3SBio Group") is pleased to announce that Kevin Xiao...


Oct 11, 2015, 20:04 ET 3SBio Signs Exclusive Patent License Agreement for ALT-P7, an Antibody-drug Conjugate Targeting HER2 with Alteogen

3SBio Inc. ("3SBio") (01530.HK), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing...


Aug 17, 2015, 10:02 ET 3SBio Inc. Selected as a Constituent of the Hang Seng Composite LargeCap & MidCap Index

3SBio Inc., (HKEX:1530) ("3SBio") today announced that effective September 14, 2015, it will be added as a constituent of the Hang Seng LargeCap...


Jul 24, 2015, 05:01 ET 3SBio Acquires Zhejiang Wansheng Pharmaceutical

- Adds integrated small molecule drug R&D and manufacturing platform - Expands product offering for chronic kidney disease and...


Jun 22, 2015, 08:55 ET 3SBio Acquires Global Rights to Anti-TNF mAb

3SBio Inc., (HKEX: 1530) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing...


Jan 25, 2015, 22:13 ET 3SBio Acquires Sirton Pharmaceuticals SpA

SHENYANG, China and VILLA GUARDIA, Italy, Jan. 25, 2015 /PRNewswire/-- 3SBio Inc., "3SBio", a leading China-based biotechnology company focused on...


Jan 14, 2015, 19:00 ET 3SBio Signs Exclusive Patent License Agreement for DIG-KT, a Bi-Specific mAb targeting VEGFR2 and Tie-2 with PharmAbcine

 3SBio Inc. ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing...


Nov 18, 2014, 19:00 ET 3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products,...


Sep 16, 2014, 20:00 ET 3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China

3SBio Inc., ("3SBio") a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing...


Aug 07, 2014, 20:00 ET 3SBio Signs Exclusive Patent License Agreement with DiNonA for Leukotuximab

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products,...


Jun 18, 2014, 02:22 ET 3SBio Inc. Exclusively Licenses Pegsiticase (Uricase PEG-20) to Selecta Biosciences to Develop Drug Candidate to Treat Gout

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing...


Oct 29, 2013, 06:09 ET 3SBio to Develop DJ5 for Progressive Renal Failure in ADPKD Patients

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical...


May 30, 2013, 08:50 ET 3SBio Inc. Announces Completion of Merger

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...


May 24, 2013, 01:51 ET 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...


May 02, 2013, 01:24 ET 3SBio Inc. Announces Extraordinary General Meeting of Shareholders

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...


May 01, 2013, 08:32 ET 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing,...


Apr 25, 2013, 04:30 ET 3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...


Apr 24, 2013, 11:53 ET 3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...


Apr 22, 2013, 14:13 ET 3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing,...


Mar 24, 2013, 10:11 ET 3SBio Inc. Announces Extraordinary General Meeting of Shareholders

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...


Mar 18, 2013, 20:00 ET 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or  "the Company"), a leading China-based biotechnology company focused on researching, developing,...


Mar 03, 2013, 08:53 ET 3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results

 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and...


Feb 08, 2013, 05:29 ET 3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction

3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...


Nov 11, 2012, 19:20 ET 3SBio Inc. Announces Unaudited Third Quarter 2012 Results

 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching,...